SODIUM HYPOCHLORITE


Synonyms	Actichlor Antiformin, dental Chlorasol Clorox Dakin's solution Dental antiformin Household bleach Hypochlorous acid, sodium salt Milton in emuls wax Milton in liq paraf Milton no.2 Natrum hypochlorosum Sodium hypochlorite Sodium hypochlorite [solution, diluted]
Status
Molecule Category	Salt-form
ATC	D08AX07
UNII	DY38VHM5OD
EPA CompTox	DTXSID8021276


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	SUKJFIGYRHOWBL-UHFFFAOYSA-N
Smiles	[Na+].[O-]Cl
InChI	InChI=1S/ClO.Na/c1-2;/q-1;+1

Physicochemical Descriptors

Property Name	Value
Molecular Formula	ClNaO
Molecular Weight	74.44
AlogP	0.13
Hydrogen Bond Acceptor	1.0
Hydrogen Bond Donor	1.0
Number of Rotational Bond	0.0
Polar Surface Area	20.23
Molecular species	NEUTRAL
Aromatic Rings	0.0
Heavy Atoms	2.0

Cross References

Resources	Reference
ChEBI	32146
ChEMBL	CHEMBL1334078
FDA SRS	DY38VHM5OD
PubChem	23665760
SureChEMBL	SCHEMBL5239

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).